Home › Funds › PRICE T ROWE ASSOCIATES INC /MD/ › GILD
PRICE T ROWE ASSOCIATES INC /MD/ position in GILD
GILEAD SCIENCES INC · Health Care
PRICE T ROWE ASSOCIATES INC /MD/ reported holding 27,664,121 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.12B, representing 0.42% of its reported portfolio and ranking #38 among its reported holdings. PRICE T ROWE ASSOCIATES INC /MD/ has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How PRICE T ROWE ASSOCIATES INC /MD/'s GILD position evolved
PRICE T ROWE ASSOCIATES INC /MD/ first disclosed a stake in GILD in Q3 2023 at 2,270,526 shares (US$170.2M). The position peaked in Q3 2026 at 27,664,121 shares, worth US$4.12B. Across 13 filings, PRICE T ROWE ASSOCIATES INC /MD/ increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 27,664,121 shares valued at US$4.12B — a reduction of -2,332,573 shares quarter over quarter.. Notable position changes include a 315% increase in Q1 2025 (shares were roughly flat over the following quarter), a 60% increase in Q2 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.27M | $170.15M | New |
| Q4 2023 | 2.82M | $228.57M | Add |
| Q1 2024 | 2.49M | $182.58M | Reduce |
| Q2 2024 | 2.85M | $195.23M | Add |
| Q3 2024 | 3.35M | $280.71M | Add |
| Q4 2024 | 3.55M | $327.61M | Add |
| Q1 2025 | 14.70M | $1.65B | Add |
| Q2 2025 | 23.59M | $2.62B | Add |
| Q3 2025 | 26.50M | $2.94B | Add |
| Q4 2025 | 27.70M | $3.40B | Add |
| Q1 2026 | 26.25M | $3.66B | Reduce |
| Q2 2026 | 30.00M | $3.79B | Add |
| Q3 2026 | 27.66M | $4.12B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 33 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- BlackRock Inc 125.25M sh · $18.67B · Q3 2026
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- DODGE & COX 21.80M sh · $3.25B · Q3 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
- Legal & General Investment Management America 10.40M sh · $1.55B · Q3 2026
- Deutsche Bank AG 9.61M sh · $1.43B · Q3 2026
More on PRICE T ROWE ASSOCIATES INC /MD/
FAQ
How long has PRICE T ROWE ASSOCIATES INC /MD/ held GILD?
PRICE T ROWE ASSOCIATES INC /MD/ has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PRICE T ROWE ASSOCIATES INC /MD/'s current position in GILD?
As of Q3 2026, PRICE T ROWE ASSOCIATES INC /MD/ holds 27.66M shares of GILD (GILEAD SCIENCES INC), valued at $4.12B, representing 0.42% of its reported portfolio and ranking #38.
Has PRICE T ROWE ASSOCIATES INC /MD/ been buying or selling GILD?
In the latest 13F filing (Q3 2026), PRICE T ROWE ASSOCIATES INC /MD/ reduced its position in GILD. The position peaked in Q3 2026 at 27.66M shares.
Which other funds hold GILD?
Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.